Deutsche Märkte geschlossen

Cardinal Health, Inc. (CAH)

NYSE - NYSE Verzögerter Preis. Währung in USD
Zur Watchlist hinzufügen
103,21-0,60 (-0,58%)
Börsenschluss: 04:00PM EDT
103,28 +0,07 (+0,07%)
Nachbörse: 07:49PM EDT

Cardinal Health, Inc.

7000 Cardinal Place
Dublin, OH 43017
United States
614 757 5000
https://www.cardinalhealth.com

Sektor(en)Healthcare
BrancheMedical Distribution
Vollzeitmitarbeiter47.040

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Mr. Jason M. HollarCEO & Director3,95MN/A1973
Mr. Aaron E. AltChief Financial Officer2,19MN/A1973
Ms. Jessica L. MayerChief Legal & Compliance Officer1,48M13,04k1970
Mr. Stephen M. MasonChief Executive Officer of Medical Segment1,23M219,53k1972
Ms. Deborah L. WeitzmanChief Executive Officer of Pharmaceutical Segment1,4MN/A1965
Ms. Patricia M. EnglishSenior Vice President451,34kN/A1980
Ms. Mary C. SchererSenior VP & Chief Accounting OfficerN/AN/AN/A
Ms. Michelle D. GreeneExecutive VP, Chief Information Officer & Customer Support ServicesN/AN/A1971
Matt SimsVice President of Investor RelationsN/AN/AN/A
Ms. Ola M. SnowChief Human Resources OfficerN/AN/A1968
Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Corporate Governance

Cardinal Health, Inc.s ISS Governance QualityScore, Stand 1. April 2024, lautet 1. Die grundlegenden Scores sind Audit: 5, Vorstand: 1, Shareholderrechte: 1, Kompensation: 2.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.